Stocksigma LogoStocksigma Logo

Brooks Laboratories Schedules Board Meeting on 7th Nov'26 for Q2 Financial Results

Brooks Laboratories Limited announced that its Board of Directors will meet on 7th Nov'26 to consider and approve the unaudited standalone and consolidated

Brooks Laboratories Schedules Board Meeting on 7th Nov'26 for Q2 Financial Results

Brooks Laboratories Ltd 路 Intimation 路 07 Nov 2026, 5:30 am

Brooks Laboratories Schedules Board Meeting on 7th Nov'26 for Q2 Financial Results Brooks Laboratories Limited announced that its Board of Directors will meet on 7th Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities, closed since 1st Oct'26 for designated persons and insiders, will reopen 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Brooks Laboratories Ltd

All Brooks Laboratories Ltd announcements